medworksmedia.com
Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit
Jenna L. Gilbert, Leigh Anne Nelson, Pharm.D., BCPP, Carrie R. Kriz, MS, Yifei Liu, B.S. Pharm, Ph.D., Courtney A. Iuppa, Pharm.D., BCPP, Lauren A. Diefenderfer, Pharm.D., BCPP, Ellie S.R. Elliott, Pharm.D., BCPP, and Roger W. Sommi, Pharm.D., BCPP, FCCP Abstract Describe primary adherence and medication persistence to second generation long-acting injectable (LAI) antipsychotics following an inpatient psychiatry hospitalization, compare rates of psychiatric-related hospital readmissions